| Bioactivity | BRL 37344 sodium (BRL 37344A) is a specific β3-adrenergic receptor agonist. BRL 37344 sodium treatment significantly lowers the body weight of obese mice[1]. |
| Target | β3-adrenergic receptor |
| In Vivo | BRL37344 sodium (BRL 37344A) treatment significantly lowers the body weight of obese mice[1]. Animal Model: |
| Name | BRL 37344 sodium |
| CAS | 127299-93-8 |
| Formula | C19H21ClNNaO4 |
| Molar Mass | 385.82 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | -20°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. Wu C, et al. Activating brown adipose tissue for weight loss and lowering of blood glucose levels: a microPET study using obese and diabetic model mice. PLoS One. 2014 Dec 2;9(12):e113742. |
BRL 37344 sodium
CAS: 127299-93-8 F: C19H21ClNNaO4 W: 385.82
BRL 37344 sodium (BRL 37344A) is a specific β3-adrenergic receptor agonist. BRL 37344 sodium treatment significantly lo
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.